Showing results (191-200 of 242) with videos related to
Sort By:
Pageof 25
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Adjuvant Bestatin immunotherapy in patients with transitional cell carcinoma of the bladder. Clinical results of a randomized trialH Blomgren, I Näslund, P L Esposti, et al.Acta Neurochirurgica|January 1, 1983
The effect of systemic human interferon-alpha administration to patients with glioblastoma multiformeJ Boëthius, H Blomgren, V P Collins, et al.Acta Radiologica. Supplementum|January 1, 1986
Stereotactic radiation therapy of intracranial arteriovenous malformationsM Lindqvist, L Steiner, H Blomgren, et al.Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Social support and immune status during and after chemotherapy for breast cancerM Lekander, C J Fürst, S Rotstein, et al.International Journal of Behavioral Medicine|January 1, 1995
Anticipatory immune changes in women treated with chemotherapy for ovarian cancerM Lekander, C J Fürst, S Rotstein, et al.Anticancer Research|July 1, 1985
Mitogen stimulation of blood lymphocytes from patients with primary intracranial tumors. Correlation to histological tumor typeU Blom, H Blomgren, H Ullén, et al.Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Adjuvant bestatin (Ubenimex) treatment following full-dose local irradiation for bladder carcinomaH Blomgren, P L Esposti, I Näslund, et al.International Journal of Radiation Oncology, Biology, Physics|February 1, 1987
Changes of the blood lymphocyte population following 131I treatment for nodular goiterH Blomgren, B Petrini, J Wasserman, et al.European Urology|January 1, 1980
Intravesical therapy with adriamycin in patients with superficial bladder tumorsF Edsmyr, T Berlin, J Boman, et al.Scandinavian Journal of Haematology|January 1, 1984
Interferon-alpha treatment of a patient with acute lymphoblastic leukaemia and Down's syndrome. Effects on natural killer cell activity and mitogen responsivenessG Bratt, S Einhorn, H Blomgren, et al.Pageof 25